China Isotope & Radiation Corporation (SEHK: 1763)
Health Care · Health Care Equipment & Supplies · CN
HK$16.66
-2.63% today · -6.7% 1Y
China Isotope & Radiation Corporation (SEHK: 1763) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $679.73M and employs 3,578 people.
Over the last twelve months the share price has lost 6.7%, trading between 15.20 and 25.00.
Tweenvest scores China Isotope & Radiation Corporation across four factors: quality 81/100, value 35/100, growth 51/100, dividend 36/100. Its strongest factor is quality.
1763 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $679.73M
- Revenue (TTM)
- $1.03B
- P/E
- 14.63
- EPS
- 1.02
- Dividend yield
- 2.15%
- Beta (5Y)
- 0.48
- 52-week high
- HK$25.00
- 52-week low
- HK$15.20
- Avg volume (3M)
- —
- Shares outstanding
- 319.87M
- Employees
- 3,578
- Next earnings
- —
About China Isotope & Radiation Corporation
China Isotope & Radiation Corporation is dedicated to the development, production, and distribution of diagnostic and therapeutic radiopharmaceuticals, as well as radioactive source products for both medical and industrial applications throughout China. The company's operations are divided into five principal areas. Its Pharmaceuticals division focuses on creating and marketing imaging diagnostic and therapeutic radiopharmaceuticals, UBT kits and analyzers, and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment furnishes medical and industrial radioactive sources, along with associated technical support services. The Irradiation segment offers sterilization services for products such as medical devices, food, traditional Chinese medicine, and cosmetics, in addition to providing engineering, procurement, and construction (EPC) services for gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment handles the sale of radiation therapy equipment and its corresponding maintenance. Finally, the Independent Clinical Medical and Laboratory Services, and Other Business segment delivers independent clinical laboratory services to hospitals and other medical institutions, covering a range of conditions including hepatitis, endocrine disorders, bone metabolism issues, cardiovascular diseases, and diabetes. Founded in 1983, the company's main office is located in Beijing, China, and it operates as a subsidiary of China National Nuclear Corporation.
- ISIN
- CNE1000031F4
- Founded
- 1983
- Listed since
- Jul 6, 2018
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $372.63 | +0.21% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.82 | +0.37% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.15 | +0.63% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.06 | -3.62% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.